Page 17 - Astrazeneca

Morocco approves use of AstraZeneca-Oxford University's Covid-19 vaccine

Morocco has approved the emergency use of the AstraZeneca Covid-19 vaccine, jointly developed with the UK's Oxford University

Free vaccines may require states to spend a third of their health Budget

While Covishield could erode a third of states' health bill if they bear the full cost, approval of the Pfizer jab would double the health spend

India's vaccine approval crucial, will boost global supply: AstraZeneca

The company has partnered with the Serum Institute of India, for the supply of the vaccine to the Indian government and also to a large number of low and middle-income countries

Is India ready for vaccine rollout? Key Covid updates of the last 24 hours

The health ministry is prepared to roll out the Covid vaccine within 10 days of the emergency use authorisation, which was granted to two companies on January 3

Vaccine firms Bharat Biotech, Serum Institute patch up after war of words

Adar Poonawalla and Krishna Ella issue joint statement saying they would work together to roll out Covid-19 vaccine

Mexico approves AstraZeneca's coronavirus vaccine for emergency use

Mexico approved the Oxford-AstraZeneca coronavirus vaccine for emergency use Monday, hoping to spur a halting vaccination effort that has only given about 44,000 shots since the third week of December

Brazil scrambles for India-made Covid vaccines to jumpstart inoculations

Brazil made a diplomatic push to guarantee an Indian-made shipment of British drugmaker AstraZeneca's Covid-19 vaccine, hoping to avoid export restrictions that could delay immunisations

UK becomes world's first to roll out Oxford vaccine as cases surge

Britain touted a scientific "triumph" as dialysis patient Brian Pinker, 82, became the first person to get the Oxford/AstraZeneca shot outside of a trial

Bharat Biotech chief takes on Serum Institute in Covid-19 vaccine war

Krishna Ella turns the tables on critics, questions approval granted to Oxford-Astra vaccine

A shot at transparency

Approval to Covaxin raises many questions

India Coronavirus Dispatch: Those already infected may still need shots

How was the nationwide dry run carried out, the next steps in the vaccine roll-out, findings from a large-scale UK study on the new variant, and more-news relevant to India's fight against Covid-19

UK begins AstraZeneca Covid-19 vaccine rollout with dialysis patient

The UK's National Health Service (NHS) on Monday began rolling out the Oxford University vaccine developed by AstraZeneca as protection against Covid-19

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO

MRP for private market Rs 1,000/ dose; current licence does not allow export or sale in private market

Serum, Bharat Biotech vaccines get restricted use approval from DCGI

While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

Next step on vaccines

Nationwide roll-out needs meticulous planning

SII will sell vaccine for Rs 200 to govt, Rs 1,000 to public: Report

He said that the vaccine will be rolled out in the next 7 to 10 days

Russia ready to trial combined AstraZeneca, Sputnik V vaccine in Ukraine

Russia's sovereign RDIF, which is marketing the Sputnik V vaccine abroad, announced in December trials to test a combination of the AstraZeneca vaccine with the Sputnik V

India approves AstraZeneca's Covid-19 vaccine for emergency use

It is the first Covid-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the United States

Covishield moves closer to roll-out; SII gets in-principle nod from panel

India would need 30 million doses in the first phase when it vaccinates the essential services workers including health care professionals, municipal and police staff, etc

Top headlines: Companies hold back on capex, GST mop-up at record high

Business Standard brings you top news of the evening